Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2a ± ribavirin in HBeAg-negative chronic hepatitis B
2004-004736-30Phase 3Completed
- Sponsor
- Erasmus MC
- Start
- Dec 2004
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Chronic Hepatitis B (CHB) comparing Peginterferon alfa-2a monotherapy with Peginterferon alfa-2a plus ribavirin (2 arms). Primary endpoint: Combined virologic and biochemical response at end of follow-up. Started Dec 2004; status: completed.
02
Drugs
interferon alfaribavirin
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2004-004736-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004736-30.